Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography

Journal of Magnetic Resonance Imaging

Volumn 18, Issue 4, 2003, Pages 449-460

  Fayad, Laura M ^a   Holland, George A ^b   Bergin, Diane ^b   Iqbal, Nasir ^b   Parker, Laurence ^b   Curcillo II, Paul G ^c   Kowalski, Thomas E ^b   Park, Pauline ^b   Intenzo, Charles ^b   Mitchell, Donald G ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bile duct abnormalities; Biliary obstruction; Cholecystitis; Contrast enhanced magnetic resonance imaging; Magnetic resonance cholangiography

Indexed keywords

MANGAFODIPIR;

ADULT; AGED; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; CHOLANGIOGRAPHY; CHOLECYSTITIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE CHOLANGIOGRAPHY; GALLBLADDER DISEASE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; REVIEW;

BILIARY TRACT; BILIARY TRACT DISEASES; CHOLECYSTITIS; CONTRAST MEDIA; EDETIC ACID; FEMALE; GALLBLADDER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYRIDOXAL PHOSPHATE; SENSITIVITY AND SPECIFICITY;

EID: 10744224024     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10369     Document Type: Review

References (33)

1. Federle M, Chezmar J, Rubin DL, et al. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. J Magn Reson Imaging 2000;12:689-670.
2. Ni Y, Petre C, Lukito G, et al. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction. Acta Radiol 1995;2:300-305.
3. Mitchell DG, Alam F. Mangafodipir trisodium: effects on T2 and T1-weighted MR cholangiography. J Magn Reson Imaging 1999;9:366-368.
4. Holland GA, Heller LE, Zegel HG, Rubin JD, Tsai FY. Functional MR cholangiography (fMRC) with breathhold ultrafast 3 dimensional spoiled gradient echo (uf3d-spgr) following intravenous mangafodipir trisodium (MnDPDP). In: American Roentgen Ray Society, May 1999, New Orleans, LA (abstract).
5. Taourel, P, Bret PM, Reinhold C, Barkun AN, Atri M. Anatomic variants of the biliary tree: diagnosis with MR cholangiopancreatography. Radiology 1996;199:521-526.
6. Fulcher AS, Turner MA, Capps GW. MR cholangiography: technical advances and clinical applications. Radiographics 1999;19:25-41.
7. Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM. Halffourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 1998;207:21-32.
8. Taylor AC, Little AF, Hennessy OF, Banting SW, Smith PJ, Desmond PV. Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc 2002;55:17-22.
9. Hintze RE, Adler A, Veltzke W. Clinical significance of magnetic resonance cholangiopancreatography compared to endoscopic retrograde cholangiopancreatography. Endoscopy 1997;29:182-187.
10. Thrall JH, Zeissman HA. Hepatobiliary system. In: Gay S, editor. Nuclear medicine, St. Louis, MO: Mosby-Year Book; 1995. p 199-204.
11. Klingensmith 3rd WC, Turner WM. Cholescintigraphy for acute cholecystitis: false positive results caused by chronic cholecystitis. Gastrointest Radiol 1990;15:129-132.
12. Shah KK, Shah KK, Fink-Bennett D, Kumar KG, McCaughey RS. Extrahepatic biliary obstruction versus intrahepatic disorder. Differentiation with hepatobiliary scintigraphy and ultrasonography. J Clin Gastroenterol 1988;10:191-196.
13. Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. J Comput Assist Tomogr 2002;26:216-222.
14. Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993;188:53-59.
15. Braga HJ, Choti MA, Le VS, Paulson EK, Siegelman ES, Bluemke DA. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization: comparison with receiver operating characteristic analysis. Radiology 2002;223:525-531.
16. Lee VS, Rofsky NM, Morgan GR, et al. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR Am J Roentgenol 2001;176:906-908.
17. Papanikolaou N, Prassopoulos P, Eracleous E, Mris T, Gogas C, Gourtsoyiannis N. Contrast-enhanced magnetic resonance cholangiography vs. heavily T2-weighted magnetic resonance cholangiography. Invest Radiol 2001;36:682-686.
18. Pandharipande, PV, Lee VS, Morgan GR, et al. Vascular and extravascular complications of liver transplantation: comprehensive evaluation with three-dimensional contrast-enhanced volumetric MR imaging and MR cholangiopancreatography. AJR Am J Roentgenol 2001;177:1101-1117.
19. Vitellas KM, El-Dieb A, Vaswani K, et al. Detection of bile duct leaks using MR cholangiography with mangafodipir trisodium (Teslascan). J Comput Assist Tomogr 2001;25:102-105.
20. Paruleker SG. Ultrasound examination of common bile duct size. Radiology 1979;133:703-707.
21. Marchal G, Ni Y, Zhang X, Yu J, Lodemann KP, Baert AL. Mn-DPDP enhanced MRI in experimental bile duct obstruction. J Comput Assist Tomogr 1993;17:290-296.
22. Irie H, Honda H, Kuroiwa T, et al. Pitfalls in MR cholangiopancreatographic interpretation. Radiographics 2001;21:23-37.
23. Morikawa M, Fukuda T, Aso N, et al. Findings of MR and MR cholangiopancreatography in acute cholecystitis. Nippon Rinsho 1998;56:2939-2945.
24. Ito K, Fukita N, Noda Y. The significance of magnetic resonance cholangiopancreatography in acute cholecystitis. Nippon Shokakibyo Gakkai Zasshi 2000;97:1472-1479.
25. Regan F, Schaefer DC, Smith DP, Petronis JD, Bohlman ME, Magnuson TH. The diagnostic utility of HASTE MRI in the evaluation of acute cholecystitis. Half-fourier acquisition single-shot turbo SE. J Comput Assist Tomogr 1998;22:638-642.
26. Behar J. Clinical aspects of gallbladder motor function and dysfunction. Curr Gastroenterol Rep 1999;1:91-94.
27. Velanovich V. Biliary dyskinesia and biliary crystals: a prospective study. Am Surg 1997;63:69-74.
28. Klieger PA, O'Mara RE. The clinical utility of quantitative cholescintigraphy: the significance of gallbladder dysfunction. Clin Nucl Med 1998;23:278-282.
29. Freeman LM, Sugarman LA, Weissmann HS. Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy. Semin Nucl Med 1981;11:186-193.
30. Moseley RH. Sepsis and cholestasis. Clin Liver Dis 1999;3:466-470.
31. Grant D, Toft KG, Martinsen I, Atzpodien E. Tissue distribution and general safety of Mn DPDP in male beagle dogs, with or without total common bile duct obstruction. Acta Radiol 1997;38:732-739.
32. Ni Y, Marchal G. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging 1998;9:183-195.
33. Koike S, Ito K, Honjo K, Takano K, Yasui M, Matsunaga N. Pharmacodynamic MR cholangiopancreatography using fatty meal and secretin stimulation. Radiat Med 2000;18:115-122.